Section 156, regulatory exclusivities granted by the FDA under the Federal Food, Drug, and Cosmetic Act, Pediatric exclusivity add-ons under PREA/BPCA, litigation outcomes under Hatch-Waxmans 30-month stay provision, and the settlement terms of any Paragraph IV challenges
Mechanisms of estradiol-induced insulin secretion by the G protein-coupled estrogen receptor GPR30/GPER in pancreatic beta-cells
INTRODUCTION We obtained medical records of 110 cases of DKA using SGLT2 inhibitors from three centers between March 2015 and December 2023
Hazard ratios and 95% CIs (shaded areas) according to ACR (A, C) adjusted for age, sex, ethnic origin, history of cardiovascular disease, systolic BP, smoking, and total cholesterol